F50.0 F50.1
Conditions
Interventions
Group 1: outpatient psychotherapy SUSTAIN via videoconference
Group 2: optimized treatment as usual TAU-O
Sponsors
Universitätsklinikum Tübingen, Innere Medizin VI, Psychosomatische Medizin und Psychotherapie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) patients with diagnosis of AN and subsyndromal AN according to DSM-5 at inpatient/ daypatient admission, (2) regular completion of inpatient/daypatient treatment, (3) minimum weight gain of 1 BMI point during inpatient/day-patient treatment, (4) BMI = 15 kg/m² at beginning of the study (T0), (5) age = 18 years, (6) written informed consent
Exclusion criteria
Exclusion criteria: (1) suicidal ideation, (2) psychotic (F20-F29) or bipolar I disorder (F30.1 - F30.8) lifetime, (3) medium to severe current substance abuse (F10.2-F19.2), (4) serious unstable medical problems (e.g. electrolyte lapse, cardiovascular, hepatic or renal disturbances) that require acute treatment (5) participation in other treatment studies, treatments, tenant groups during T0-T2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| difference of BMI between study inclusion (T0) and end of treatment (T2) | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) BMI course over five assessment points: T(-1) admission to inpatient/day-patient care, T0 study inclusion and randomisation in the last week of inpatient/daypatient care, T1 interim assessment 4 months +/- 2 weeks after treatment start, T2 end of treatment +/- 2 weeks; T3 6 months follow-up +/- 1 month; (2) proportion of relapse; (3) eating disorder pathology, (4) general psychopathology, (5) cost-effectiveness, (6) time to dropout from the post-inpatient treatment | — |
Countries
Germany
Contacts
Public ContactKatrin Giel
Universitätsklinikum Tübingen, Innere Medizin VI, Psychosomatische Medizin und Psychotherapie
Outcome results
None listed